Table 2.
Concentration of sST2 (in ng mL–1) obtained from the measurements carried out with the immune platform and the ELISA method in plasma samples.
| Subjects | Sample | Immune Platform | ELISA | texp | ttab | ||
|---|---|---|---|---|---|---|---|
| [sST2] 1 | RSDn = 3, % | [sST2] 1 | RSDn = 3, % | ||||
| Healthy individuals | 1 | (5.5 ± 0.8) | 6.1 | (5 ± 1) | 9.3 | 0.009 | 2.776 |
| 2 | (4.7 ± 0.2) | 1.3 | (4.4 ± 0.7) | 6.8 | 1.519 | ||
| 3 | (15 ± 1) | 3.6 | (15 ± 2) | 6.3 | 0.016 | ||
| 4 | (3.1 ± 0.6) | 7.7 | (2.6 ± 0.5) | 7.9 | 2.518 | ||
| 5 | (10.8 ± 0.7) | 2.5 | (10 ± 2) | 6.6 | 1.752 | ||
| 6 | (8 ± 1) | 6.0 | (8 ± 4) | 9.8 | 0.680 | ||
| PDAC patients | 7 | (168 ± 6) | 1.3 | (166 ± 28) | 3.9 | 0.468 | |
| 8 | (22 ± 2) | 3.6 | (20 ± 4) | 4.5 | 2.515 | ||
| 9 | (164 ± 18) | 4.4 | (160 ± 12) | 1.7 | 0.933 | ||
| 10 | (83 ± 6) | 3.2 | (83 ± 15) | 4.3 | 0.098 | ||
| 11 | (22 ± 4) | 8.1 | (25 ± 7) | 6.9 | 1.767 | ||
1 (mean value ± t × s/√n, n = 3).